These results, together with a prior report showing that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 assist the strategy of concentrating on ACKR3 as a unique solution to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-relevant Issues.These final results advise that conolid